Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2000
Single User License Price INR 134900
Hard Copy License Price USD 3000
Hard Copy License Price INR 202350
Corporate User License Price USD 4000
Corporate User License Price INR 269800
Request a Quote

Report Title

Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region

Quote Request for License Type
License Type Price  
Single User License USD 2000
Hard Copy License USD 3000
Enterprise Wide License USD 4000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region


Quote Request for License Type
License Type Price  
Single User License USD 2000
Hard Copy License USD 3000
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region



Executive Summary

The report titled "Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region" provides information on market size for Indonesia Healthcare and pharmaceutical.


Indonesia Pharmaceutical Market Ecosystem

 

The report covers aspects such as healthcare market segment (by hospitals, pharmaceuticals, medical devices and clinical laboratory), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market, and covering competitive landscape of major pharmaceutical companies including PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk, Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Indonesia Pharmaceutical Market
Indonesia Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017.

By Therapeutic Segment: Anti-infective drug sale has contributed to the largest share of ~% in the revenue share of Indonesia Pharmaceutical industry in 2017. This is mainly due to high prevalence of bacterial and communicable diseases. This is followed by Gastrointestinal and metabolism drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system drugs with ~%, Respiratory system drugs with ~%, Musculoskeletal system drugs with ~%, dermatology drugs with ~%, genitourinary and hormonal drugs with ~%, blood related drugs with ~%, oncology with ~% and rest of the therapeutic segments with ~% of the revenue share in 2017.

By Domestic and International Players: Domestic players have accounted for ~% of the revenue in Indonesia pharmaceutical market in 2017 driven by the implementation of JKN (National Health Insurance System) in 2014. International players have captured ~% of the revenue share in 2017 driven by favorable government norms for foreign ownership.

By Generic and Patented Drug: Generic drugs have accounted for the major revenue share of ~% in 2017 driven by the increased demand from government run hospitals and clinics. The share of patented drugs has increased from ~% in 2013 to ~% in 2017. Further, ethical generic drugs have accounted for ~% of the Indonesia generic drug market revenue in 2017 followed by free sale drugs with ~% and unbranded drug sale with ~%.

By OTC and Prescription Drugs: The Prescription drugs sales have accounted for ~% of the revenue share in Indonesia Pharmaceuticals Market. OTC drugs have accounted for ~% of the revenue share in 2017. This segment is driven by increased tendency of Indonesians to treat them and take self medication
By Domestic Sales and Exports: Domestic sales have accounted for a majority revenue share of ~% in 2017 whereas exports have accounted for a small share of ~%. The domestic market is dominated by the sale of low priced ethical generic medicines.

Indonesia Pharmaceutical Market Competition Overview
Indonesia Pharmaceutical market is dominated by domestic players which control ~% of the market in 2017. Recent favorable government regulations have facilitated the entry of foreign players in the space. There are 206 pharmaceutical companies (182 domestic and 24 international companies) located in Indonesia and ~% of them are located in Java in 2016. These players compete on the basis of distribution network, product portfolio, marketing activities and research and development. The domestic players dominate the generic drug and over the counter drug segment. International players have better expertise, skilled labor and infrastructure to produce such medicines at competitive prices. While domestic companies dominate the market for low cost generic drugs, multinational players have taken over high-demand, specialized segments and pharmaceuticals services ranging from capsule provision to instrumentation and packaging.

Indonesia Pharmaceutical Market Future Potential
Indonesia pharmaceutical industry is expected to increase from USD ~ billion in 2018 to USD ~ billion at a growth rate of ~%. The industry growth will be led by Indonesia’s large population and growing middle-income class, supportive government policies and higher investment in the industry. With the increase in incidence of communicable diseases such as HIV, TB, therapeutic segments such as anti infectives and respiratory are expected to grow. Major companies are expected to increase investment in nutritional and herbal medicines due to changing preference in the industry. Apart from manufacturing generic and patented drugs, pharmaceutical companies will shift focus to other niche segments such as combined dosages, novel drug delivery areas. Further in order to overcome the shortcomings, Contract Development and Manufacturing Organizations (CDMOs) will emerge as an attractive resource for manufacturers seeking to expand their capacities.

Key Topics Covered in the Report:

  • Indonesia Healthcare Market Size, 2012-2017
  • Indonesia Pharmaceutical Market Size, 2012-2017
  • Indonesia Pharmaceutical Market Segmentation (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region)
  • Trends and Developments in Indonesia Pharmaceutical Market
  • Issues and Challenges in Indonesia Pharmaceutical Market
  • Government Initiatives, Rules and Regulations in Indonesia Pharmaceutical Market
  • Indonesia Pharmaceutical Market Competitive Landscape
  • Indonesia Pharmaceutical Future Outlook and Projections, 2018-2022
  • Indonesia Healthcare Future Outlook and Projections, 2018-2022
  • Analyst Recommendations
  • Macro-economic Factors Impacting Indonesia Healthcare Market

1. Executive Summary
Indonesia Healthcare Market Overview
Indonesia Pharmaceutical Market Segmentation
Indonesia Pharmaceutical Market Competition Overview
Indonesia Pharmaceutical Market Future Potential
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Consolidated Research Approach
Market Sizing – Pharmaceutical Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
3. Indonesia Healthcare Market Size, 2012-2017
4. Indonesia Pharmaceutical Market Introduction
4.1. Indonesia Pharmaceutical Market Size, 2012-2017
5. Indonesia Pharmaceutical Market Segmentation, 2017
5.1. By Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2015 & 2017
Vitamins and Dietary Supplements Market, 2012-2017
5.2. By Domestic and International Players, 2012-2017
5.3. By Generic and Patented Drug, 2017
By Type of Generic Drugs (Unbranded, Ethical and Free Sales), 2013 and 2017
5.4. By OTC and Prescription Drugs, 2012-2017
5.5. By Domestic Sales and Exports, 2012-2016
5.6. By Region (West Java, East Java, Central Java, Jakarta and Others), Dec 2016
6. Trends, Developments and Restraint in Indonesia Pharmaceutical Market
Growth in Indonesia Animal Pharmaceutical and Vaccine Market
Increased Government Support
Rise in Mergers and Acquisitions Activities
Growing Investment from Foreign Companies
Dependence on Imports for API (Active Pharmaceutical ingredient) Procurement
Other Challenges Faced
7. Government Regulations for Indonesia Pharmaceutical market
Pharmaceutical Finished Products Registration Requirement
Registration Procedure
Pharmaceutical Raw Materials
Advertising and Distribution
FDI in Pharmaceutical Industry
Procedure of Applying for Patent in Indonesia
Import Regulations
Draft Law on Monitoring of Pharmaceutical Supply, Medical Devices and Household Health Products
Draft law on Hala Product Guarantee
Regulations for Non-Indonesian Stakeholders Planning to Enter the Pharmaceutical Market
8. Indonesia Biopharmaceutical Industry Snapshot
Innogene Kalbiotech
9. Snapshot on Indonesia Vaccine Market
10. Competitive Scenario for Major Players in Indonesia Pharmaceutical Market
10.1. Market Share of Major Players in Indonesia Pharmaceutical Market, 2015
11. Competitive Landscape of Major Players in Indonesia Pharmaceutical Market
11.1. PT Kalbe Farma
Product Portfolio for PT Kalbe Farma
11.2. PT Sanbe Farma
Product Portfolio for PT Sanbe Farma
11.3. PT SOHO Global Health
11.4. PT Dexa Medica
Product Portfolio for Dexa Medica
11.5. PT Pharos
Product Portfolio for PT Pharos
11.6. PT Kimia Farma
Product Portfolio for PT Kimia Farma
11.7. PT Tempo Scan Pacific Tbk
Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
11.8. PT Merck Tbk
11.9. Overview for Other Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market
12. Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
12.1. By Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2022
12.2. By Generic and Patent Drugs, 2022
13. Analyst Recommendations
14. Macro Economic Factors Affecting Indonesia Healthcare Market
14.1. Population, 2012-2022
14.2. Number of Health Centers, 2012-2022
14.3. Budget Allocation on Healthcare, 2012-2022
14.4. Obese Population, 2012-2022
Disclaimer
Contact Us

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Figure 1-1: Indonesia Pharmaceutical Market Flowchart
Figure 3-1: Indonesia Healthcare Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 4-1: Indonesia Pharmaceutical Market Size on the Basis of Revenue in USD Billion and Growth Rate in Percentage (%), 2012-2017
Figure 5-1: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in Percentage (%), 2017
Figure 5-2: Indonesia Vitamin and Dietary Supplements Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2012-2017
Figure 5-3: Indonesia Vitamin and Dietary Supplements Market Segmentation by Distribution Channel on the Basis of Revenue in Percentage (%), 2017
Figure 5-4: Market Share of Major Companies in Indonesia Vitamin and Dietary Supplements Market on the Basis of Revenue in Percentage (%), 2017
Figure 5-5: Indonesia Pharmaceutical Market Segmentation by Domestic and International Players on the Basis of Revenue in Percentage (%), 2012-2017
Figure 5-6: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Revenue in Percentage (%), 2017
Figure 5-7: Indonesia Generic Drug Market Segmentation by Type (Unbranded, Ethical and Free Sales) on the Basis of Revenue in Percentage (%), 2017
Figure 5-8: Indonesia Pharmaceutical Market Segmentation by OTC and Prescription Drugs on the Basis of Revenue in Percentage (%), 2012-2017
Figure 5-9: Indonesia Pharmaceutical Market Segmentation by Domestic Sales and Exports on the Basis of Revenue in Percentage (%), 2012-2016
Figure 5-10: Indonesia Pharmaceutical Market Segmentation by Region (West Java, East Java, Central Java, Jakarta and Others) on the Basis of Number of Companies in Percentage (%), as of Dec 2016
Figure 6-1: Indonesia Animal Pharmaceutical and Vaccine Market Size on the Basis of Revenue in USD Million, 2012-2017
Figure 7-1: Process of Establishing a Pharmaceutical Company in Indonesia
Figure 9-1: Indonesia Pharmaceutical Market Segmentation on the Basis of Vaccine and Other Pharmaceutical Drugs on the Basis of Revenue in Percentage (%), 2017
Figure 10-1: Indonesia Pharmaceutical Market Share of Major Players on the Basis of Revenue in Percentage (%), 2015
Figure 12-1: Indonesia Pharmaceutical Market Future Projections on the Basis of Revenue in USD Billion, 2018-2022
Figure 12-2: Indonesia Pharmaceutical Market Future Outlook and Projections by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in Percentage (%), 2022
Figure 12-3: Indonesia Pharmaceutical Market Future Projections by Generic and Patent Drugs on the Basis of Revenue in Percentage (%), 2022
Figure 14-1: Population of Indonesia in Million, 2012-2022
Figure 14-2: Number of Health Centers in Indonesia, 2012-2022
Figure 14-3: Budget Allocation on Healthcare in Indonesia in IDR Trillion, 2012-2022
Figure 14-4: Obese Population in Indonesia in Million, 2012-2022

Table 2-1: Therapeutic Segments Covered in Indonesia Pharmaceutical Market
Table 2-2: Correlation Matrix for Indonesia Healthcare Market
Table 2-3: Regression Coefficients Output
Table 3-1: Key Developments in Indonesia Healthcare Market, 2012-2017
Table 3-2: Change in Foreign Investment Regulation in Different Healthcare Verticals in Indonesia
Table 4-1: Introduction for Indonesia Pharmaceutical Industry
Table 4-2: Key Developments in Indonesia Pharmaceutical Market, 2012-2017
Table 5-1: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in USD Million, 2015 and 2017
Table 5-2: Indonesia Pharmaceutical Market Segmentation by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Best Selling Medicines, major Companies and OTC and Prescribed
Table 5-3: Indonesia Vitamin and Dietary Supplements Market Segmentation by Distribution Channel on the Basis of Revenue in USD Million, 2017
Table 5-4: Market Share of Major Companies in Indonesia Vitamin and Dietary Supplements Market on the Basis of Revenue in USD Million, 2012-2017
Table 5-5: Indonesia Pharmaceutical Market Segmentation by Domestic and International Players on the Basis of Revenue in USD Billion, 2012-2017
Table 5-6: Key Takeaways for Indonesia Pharmaceutical Market Segmentation by Domestic and International Players
Table 5-7: Major Therapeutic Segments for Domestic and International Companies
Table 5-8: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Revenue in USD Billion, 2017
Table 5-9: Indonesia Pharmaceutical Market Segmentation by Generic and Patented Drugs on the Basis of Best Selling Medicines, Major Companies and Therapeutic Class
Table 5-10: Indonesia Generic Drug Market Segmentation by Type (Unbranded, Ethical and Free Sales) on the Basis of Revenue in USD Billion, 2013 and 2017
Table 5-11: Indonesia Pharmaceutical Market Segmentation by OTC and Prescription Drugs on the Basis of Revenue in USD Billion, 2012-2017
Table 5-12: Indonesia Pharmaceutical Market Segmentation by Domestic Sales and Exports on the Basis of Revenue in USD Million, 2012-2016
Table 5-13: Indonesia Pharmaceutical Products Export by Value in USD Thousand, 2014-2016
Table 5-14: Indonesia Pharmaceutical Market Segmentation by Region (West Java, East Java, Central Java, Jakarta and Others) on the Basis of Number of Companies, as of Dec 2016
Table 6-1: Major Mergers, Acquisitions and Joint Ventures in Indonesia Pharmaceutical Industry during 2012-2017
Table 6-2: Major Alliances in Indonesia Pharmaceutical Industry
Table 7-1: Registration of Finished Pharmaceutical Products in Indonesia
Table 7-2: Procedure for Applying for Patent in Indonesia.
Table 8-1: Snapshot for Indonesia Biopharmaceutical Industry
Table 8-2: Competitive Landscape of Innogene Kalbiotech including Overview, Products and Services, Partners and Business Strategies
Table 9-1: Indonesia Pharmaceutical Market Segmentation on the Basis of Vaccine and Other Pharmaceutical Drugs on the Basis of Revenue in USD Billion, 2017
Table 10-1: Competitive Parameters in Indonesia Pharmaceutical Market
Table 10-2: Rationale for Market Share of Major Players in Indonesia Pharmaceutical Market, 2015
Table 10-3: Market Share of Major Players in Indonesia Pharmaceutical Market on the Basis of Revenue in USD Million, 2015
Table 11-1: Competitive Landscape of PT Kalbe Farma including Company Overview, USP, Business Segments, Corporate Social Responsibility, Certifications and Accreditations, Manufacturing Plants, Business Strategies, Number of Employees, Best Selling products, New Product Launches and Recent Developments
Table 11-2: Market Share of Major Products of PT Kalbe Farma on the Basis of Volume in Percentage (%), 2016
Table 11-3: Manufacturing Facility of PT Kalbe Farma
Table 11-4: Product Portfolio for PT Kalbe Farma, Indonesia
Table 11-5: Competitive Landscape of PT Sanbe Farma including Company Overview, USP, Product Segments, Subsidiaries, Certifications and Accreditations, Plants, Future Strategies, Number of Employees and Distribution Network
Table 11-6: Product portfolio for PT Sanbe Farma, Indonesia
Table 11-7: Competitive Landscape of PT SOHO Global Health including Company Overview, USP, Product Segments, Subsidiaries, Certifications and Accreditations, Plants, Future Strategies, Number of Employees and Distribution Network
Table 11-8: Competitive Landscape of PT Dexa Medica including Company Overview, USP, Product Segments, Business Strategies, Estimate Revenue and Number of Employees
Table 11-9: Major Products Portfolio for PT Dexa Medica, Indonesia
Table 11-10: Competitive Landscape of PT Pharos including Company Overview, USP, Product Segments, Business Strategies and Number of Employees
Table 11-11: product Portfolio for PT Pharos, Indonesia
Table 11-12: Competitive Landscape of PT Kimia Farma including Company Overview, Strength, Product Segments, Business Strategies and Number of Employees
Table 11-13: Type of Products manufactured at Different Manufacturing Facilities of Kimia Farma, Indonesia
Table 11-14: Major Products Portfolio for PT Kimia Farma, Indonesia
Table 11-15: Competitive Landscape of PT Tempo Scan Pacific Tbk including Company Overview, USP, Product Line, Business Division, Distribution Network, Corporate Social Responsibility, Business Strategies and Number of Employees
Table 11-16: Manufacturing Facility for PT Tempo Scan Pacific Tbk, Indonesia
Table 11-17: Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
Table 11-18: Competitive Landscape for PT Merck Tbk including Company Overview, Business Segments, Key Stats, Best Selling products and Business Strategy
Table 11-19: Key products in Biopharma Division for Merck Indonesia on the Basis of Therapeutic Segment
Table 11-20: Key products in Consumer Health Division for Merck Indonesia on the Basis of Therapeutic Segment
Table 11-21: Overview of Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market
Table 12-1: Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
Table 12-2: Indonesia Pharmaceutical Market Future Outlook and Projections by Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others) on the Basis of Revenue in USD Billion, 2022
Table 12-3: Indonesia Pharmaceutical Market Future Outlook and Projections by Generic and Patent Drugs on the Basis of Revenue in USD Billion, 2022
Table 13-1: Analyst Recommendation for Indonesia Pharmaceutical Market
Table 14-1: Key Developments in Population of Indonesia, 2012-2022
Table 14-2: Key Developments in Number of Health Centers in Indonesia, 2012-2022
Table 14-3: Key Developments in Budget Allocation on Healthcare in Indonesia, 2012-2022
Table 14-4: Key Developments in Obese Population in Indonesia, 2012-2022

Single User License:
Access to the content will be granted to individual user ("Authorized User") within the organization The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose.

Hard Copy License:
The license provides the access to hard copy/ printed copy of the report to the Authorized User. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will not only use this for internal purpose.

Corporate User License:
Access to the content will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose.

PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk, Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex

Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology, Prescribed Drug, Generic Drug, OTC Drug, Patented Drug, Domestic Sales, Export


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand